Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

authors

• Trotman Judith
• Barrington Sally F
• Belada David
• Meignan Michel
• Macewan Robert
• Owen Carolyn
• Ptáčn'Ik Václav
• Rosta András
• Fingerle-Rowson Günter R
• Zhu Jiawen
• Nielsen Tina
• Sahin Deniz
• Hiddemann Wolfgang
• Marcus Robert E
• Davies Andrew
• Hertzberg Mark
• Grigg Andrew
• Cannell Paul
• Quach Hang
• Opat Stephen
• Tam Constantine
• Marlton Paula
• Janssens Ann
• Offner Fritz
• van Eygen Koen
• Sangha Randeep
• Mckay Pam
• Wilson Jonathan
• van Der Jagt Richard
• Roitman Daryl
• Trneny Marek
• Mayer Jiri
• Le Du Katell
• Solal-Celigny Philippe
• Cartron Guillaume
• Foussard Charles
• Frickhofen Norbert
• Schmidt Peter
• Graeven Ullrich
• Gaska Tobias
• Schlag Rudolf
• Sökler Martin
• Prange-Krex Gabriele
• Florschütz Axel
• Lindemann Hans-Walter
• Schimmelpfennig Christoph
• Tonndorf Solveig
• Hänel Mathias
• Hess Georg
• Schalk Enrico
• Hütten Heiko
• Doelken Gottfried
• Pfreundschuh Michael
• Keller Ulrich
• Herold Michael
• Forstpointner Roswitha
• Vehling-Kaiser Ursula
• Hoffmann Martin
• Borbényi Zita
• Udvardy Miklos
• Demeter Judit
• Rambaldi Alessandro
• Morra Enrica
• Massimo Federico
• Majolino Ignazio
• Balzarotti Monica
• Semenzato Gianpietro
• Canales Albendea Miguel Angel
• Peñalver Parraga Francisco Javier
• Soler Campos Alfonso
• Sancho Cia Juan Manuel
• Marquez Navarro Jose Antonio
• Grande Garcia Carlos
• Nilsson-Ehle Herman
• Mccarthy Helen
• Pocock Chris
• Sadullah Shalal
• Malladi Ram
• Radford John
• Kanfer Ed
• Kruger Anton
• Culligan Dominic
• Dyer Martin
• Pettengell Ruth
• Seymour John
• Gribben John
• Al-Ismail Saad
• Al-Refaie Faris
• Blesing Norbert
• Macnamara Christopher
• O'Callaghan Ann
• Haynes Andrew
• Follows George
• Johnson Roderick
• Cunningham David
• Bowles Kristian
• Collins Graham
• Gallop-Evans Eve
• Robinson Stephen
• Subash Chezhian
• Bailey James
• Holden Viran
• Neidhart Jeffrey
• de Oliveira Moacyr
• Tezcan Haluk
• Kim Kevin
• Kambhampati Suman
• Lanier Keith
• Mcclean John
• Tobinai Kensei

document type

abstract

PET investigators from the GALLIUM study (2018). Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial. The Lancet Oncology.

more information